Immediapress - il Centro Tirreno
Il sito "il Centro Tirreno.it" utilizza cookie tecnici o assimiliati e cookie di profilazione di terze parti in forma aggregata a scopi pubblicitari e per rendere più agevole la navigazione, garantire la fruizione dei servizi, se vuoi saperne di più leggi l'informativa estesa, se decidi di continuare la navigazione consideriamo che accetti il loro uso.
13
Lun, Apr

Abbiamo 2466 visitatori e nessun utente online

Immediapress

Comunicati stampa sponsorizzati

Lugano 14 Giugno 2021 - La Svizzera è il maggiore produttore di CBD in Europa, e questa industria sembra essere in continua crescita e non avere nessuna intenzione di fermarsi. Perché? La risposta è semplice: questo paese ha infatti aperto ad una maggiore legalizzazione dei prodotti a base di CBD, pur lasciando però

• Gli Easy Rack sono veloci da installare, semplici da usare e facili da gestire  

• I rack di alta qualità offrono maggiore affidabilità e convenienza per le implementazioni edge e Data Center  

• Il design standardizzato offre la massima interoperabilità e scalabilità per le

Aggiornamento professionale sul “Fashion Law”  

3° appuntamento della rubrica ideata da CSB, giovedì 24 giugno 2021, ore 16.00  

Milano, 14 giugno 2021 - Da sempre attento alle esigenze del mondo legal, Centro Studi Borgogna ha ideato la rubrica “Fashion Law”: cinque appuntamenti

LONDON, June 14, 2021 /PRNewswire/ -- Klöckner Pentaplast (kp or the company), a leading global manufacturer of high barrier protective packaging solutions with industry-leading use of recycled content, has been awarded a gold rating by EcoVadis, the independent provider of global sustainability ratings for environmental, social, and

GAITHERSBURG, Md., June 14, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. The

La partnership con l’organizzazione in prima linea per l’equilibrio di genere marca ulteriormente l’impegno dell’azienda nei confronti della Gender Inclusion  

 

Milano, 14 giugno 2021 – Snaitech ha annunciato oggi – durante la Snaitech Sustainability Week – il suo ingresso in

AMSTERDAM, June 14, 2021 /PRNewswire/ -- The US Office of the Comptroller of the Currency (OCC) has approved Adyen's application to establish a Federal Foreign Branch in San Francisco, California. The OCC's approval and its granting of the branch charter in combination with the Federal Reserve's approval of the application on May 24, 2021

BEIJING, June 13, 2021 /PRNewswire/ -- China's eastern Zhejiang province is expected to make substantial progress in building a demonstration zone for common prosperity through high-quality development, according to a guideline released by the Communist Party of China Central Committee and the State Council on Thursday. 

The

BEIJING, June 12, 2021 /PRNewswire/ -- The Chinese people have long valued the importance of setting lofty goals and striving for them with persistence. "No ambition, no achievement," said Wang Yangming (1472-1529), a Chinese thinker in the Ming Dynasty. 

Chinese President Xi Jinping quoted Wang's words in May 2018 to encourage

BEIJING, June 12, 2021 /PRNewswire/ -- With the conviction that openness is the way to growth and wealth, Chinese President Xi Jinping has called on China and the rest of the world to expand cooperation and build a community with a shared future for mankind.While attending the APEC CEO Summit in Bali, Indonesia back in November 2013, the

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ -- The phase 3 MAIA study evaluated D-Rd versus Rd in 737 patients who were ineligible for high-dose chemotherapy and autologous stem cell transplantation. The primary analysis of MAIA demonstrated a 44% reduction in the risk of disease progression or death after treatment with D-Rd compared

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ - The combination of ibrutinib and venetoclax may be effective for treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) due to the complementary mechanisms of action of the two targeted therapies. Ibrutinib mobilizes CLL cells from the lymph nodes and

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ -- The PEGASUS phase-3 study previously demonstrated that pegcetacoplan, a drug controlling intra- and extravascular hemolysis, was superior to eculizumab in patients with paroxysmal nocturnal hemoglobinuria at the week 16 endpoint of the randomized controlled period (RCP). After week 16,